The biological actions of leptin are mediated largely through interaction with its cognate receptor (Ob-RL) expressed in several peripheral tissues including human hepatic cells, which attenuates some insulin-induced activities causing insulin resistance, whereas increased insulin resistance represents an almost universal finding in subjects with NAFLD suggesting a role for leptin [6]. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.